Catalyst Pharma (CPRX) Investigational Drug CPP-115 Gets FDA Fast-Track Designation
Up)
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) reports its investigational drug, CPP-115, a novel GABA aminotransferase inhibitor, has been designated as a Fast Track development program by the FDA for the treatment of cocaine dependency.
CPP-115 is a novel GABA aminotransferase inhibitor and vigabatrin analogue that is more potent than vigabatrin and has reduced side effects from those associated with vigabatrin in preclinical studies. Catalyst is planning to develop CPP-115 for several indications, including drug addiction, epilepsy and other selected CNS diseases, and recently initiated a Phase I(a) safety study in 48 healthy subjects. CPP-115 has also been granted orphan-drug designation by the FDA for the treatment of infantile spasms.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
CPP-115 is a novel GABA aminotransferase inhibitor and vigabatrin analogue that is more potent than vigabatrin and has reduced side effects from those associated with vigabatrin in preclinical studies. Catalyst is planning to develop CPP-115 for several indications, including drug addiction, epilepsy and other selected CNS diseases, and recently initiated a Phase I(a) safety study in 48 healthy subjects. CPP-115 has also been granted orphan-drug designation by the FDA for the treatment of infantile spasms.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Catalyst Pharma (CPRX) Shares Jump 20% as CPP-115 Safe, Well Tolerated Across All Doses
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
Create E-mail Alert Related Categories
Corporate News, FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
